Cargando…
HDAC inhibitor valproic acid protects heart function through Foxm1 pathway after acute myocardial infarction
BACKGROUND: Epigenetic histone acetylation is a major event controlling cell functions, such as metabolism, differentiation and repair. Here, we aim to determine whether Valproic acid (VPA), a FDA approved inhibitor of histone deacetylation for bipolar disease, could protect heart against myocardial...
Autores principales: | Tian, Shuo, Lei, Ienglam, Gao, Wenbin, Liu, Liu, Guo, Yijing, Creech, Jeffery, Herron, Todd J., Xian, Shaoxiang, Ma, Peter X., Eugene Chen, Y., Li, Yongqing, Alam, Hasan B., Wang, Zhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354709/ https://www.ncbi.nlm.nih.gov/pubmed/30552062 http://dx.doi.org/10.1016/j.ebiom.2018.12.003 |
Ejemplares similares
-
Acetyl-CoA production by specific metabolites promotes cardiac repair after myocardial infarction via histone acetylation
por: Lei, Ienglam, et al.
Publicado: (2021) -
Transplantation of Isl1(+) cardiac progenitor cells in small intestinal submucosa improves infarcted heart function
por: Wang, Lingjun, et al.
Publicado: (2017) -
Inhibition of leukemic cells by valproic acid, an HDAC inhibitor, in xenograft tumors
por: Zhang, Zhihua, et al.
Publicado: (2013) -
HDAC inhibitor valproic acid upregulates CAR in vitro and in vivo
por: Segura-Pacheco, Blanca, et al.
Publicado: (2007) -
Potential repurposing of the HDAC inhibitor valproic acid for patients with COVID-19
por: Pitt, Bertram, et al.
Publicado: (2021)